Facts about SARS CoV-2 and
how to prevent infection
Across all business segments, HARTMANN generated sales revenues of EUR 1,710.2 million in the period from January to September 2022. The organic decline in sales was -1.0% compared to the same period of the previous year. The Company generated adjusted EBITDA of EUR 139.0 million, a de-crease of EUR -53.0 million compared to the same period in 2021.
Our society could not function without family managers. Yet their dedication often goes unacknowledged.
Millions of people live with urinary incontinence. One in five of us aged over 40 has the condition. Yet it remains a subject we don’t seem comfortable talking about; with many suffering in silence rather than asking for the help that’s out there. Isn’t it time to break one of the last remaining taboos in health?
It is an exciting time to work in healthcare. Healthcare faces some tough challenges such as budget cuts, ageing populations, and increases in non-communicable diseases. That means there are plenty of opportunities to shape the healthcare of the future. HARTMANN has challenged healthcare conventions for 200 years and continues to go further with product solutions for hospitals that protect surgical teams and let them and the hospital work more efficiently. HARTMANN offers wound treatments that make health economic sense and bring simplicity to patients and caregivers’ lives. HARTMANN provides discreet solutions for people with incontinence that preserve their dignity. And HARTMANN continues to pioneer disinfection solutions for healthcare professionals all over the world.
Join HARTMANN and take an active role in shaping the future of healthcare. We are looking for people who can inspire and help us Go further for health.
